Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and ...
Best laser cutters and engravers for home use 2025
Best laser cutters and engravers for home use 2025 - Explore the top laser cutters and engravers of 2025, perfect for ...
DRIFT Returns to Milan Design Week With Audi-Backed Installation
After a 10-year absence, Amsterdam-based studio DRIFT is back at Milan Design Week with a new installation created in ...
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
Studies conducted in human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) compared various cassette configurations and informed the final design of TN-201, which incorporates a ...
Imunon, Inc.: IMUNON Finalizes Phase 3 Study Design with FDA for IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation of trial sites underway for ground-breaking Phase 3 pivo ...